Yarbrough Capital, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Yarbrough Capital, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$389,256
+12.4%
2,4480.0%0.02%
+15.0%
Q2 2023$346,294
-16.0%
2,4480.0%0.02%
-41.2%
Q1 2023$412,145
-0.6%
2,4480.0%0.03%
+3.0%
Q4 2022$414,471
-9.5%
2,4480.0%0.03%
-10.8%
Q3 2022$458,000
+15.1%
2,4480.0%0.04%
+23.3%
Q2 2022$398,0002,4480.03%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders